1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | -5.57M | 1.80% |
| EBITDA | -6.5M | 18.97% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €31.83M |
Number of shares | 15M |
52-week high/low | €5.03 - €1.05 |
| Dividends | No |
Beta | 0.03 |
P/E ratio | -1.31 |
PEG ratio | 0.03 |
P/B ratio | 2.15 |
P/S ratio | 0.00 |
Company profile
| Name | AgeX Therapeutics Aktie |
| CEO | Steven A. Ledger |
| IPO | 01/21/2000 |
| Employees | 16 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | SER |
Frankfurt | 2BO.F |
Discover assets
Shareholders of AgeX Therapeutics Aktie also invest in the following assets
